Silva Markovic-Plese Selected Research

Interferons

1/2016	Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
11/2015	Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.
9/2010	Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silva Markovic-Plese Research Topics

Disease

23	Relapsing-Remitting Multiple Sclerosis 01/2024 - 05/2004
22	Multiple Sclerosis 01/2022 - 05/2004
6	Demyelinating Diseases (Demyelinating Disease) 12/2018 - 01/2008
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2005
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 12/2018
4	Inflammation (Inflammations) 11/2015 - 06/2009
3	Neuroinflammatory Diseases 01/2021 - 03/2008
3	Disease Progression 03/2015 - 04/2005
1	Bites and Stings (Sting) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Mobility Limitation (Difficulty Walking) 01/2021
1	Cognitive Dysfunction 03/2015
1	Atrophy 03/2015
1	Lymphopenia (Lymphocytopenia) 12/2013
1	HIV Infections (HIV Infection) 06/2011
1	Infections 06/2009
1	Opportunistic Infections (Opportunistic Infection) 11/2008
1	Brain Edema (Cerebral Edema) 11/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2008
1	Alzheimer Disease (Alzheimer's Disease) 03/2008
1	Brain Injuries (Brain Injury) 03/2008
1	Brain Neoplasms (Brain Tumor) 03/2008
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 04/2005
1	Virus Diseases (Viral Diseases) 04/2005
1	Paresthesia (Dysesthesia) 04/2005
1	X-Linked Bulbo-Spinal Atrophy 04/2003

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 01/2008
4	Monoclonal AntibodiesIBA 01/2022 - 06/2004
4	Interleukin-11 (Interleukin 11)IBA 01/2019 - 06/2015
4	Interferon beta-1a FDA Link 11/2015 - 01/2014
4	AntigensIBA 07/2013 - 04/2005
4	Simvastatin (Zocor)FDA LinkGeneric 01/2013 - 05/2004
4	Interferon-betaIBA 09/2010 - 06/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 09/2006
3	InterferonsIBA 01/2016 - 09/2010
2	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2021 - 09/2018
2	VaccinesIBA 01/2021 - 12/2005
2	Interleukin-17 (Interleukin 17)IBA 12/2018 - 01/2008
2	Chemokine CX3CL1IBA 04/2015 - 02/2012
2	Alemtuzumab (Campath)FDA Link 12/2013 - 07/2013
2	AutoantigensIBA 02/2012 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 06/2011 - 04/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2008 - 04/2005
1	LipidsIBA 01/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	Therapeutic UsesIBA 01/2022
1	activin AIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-27 (Interleukin 27)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	Interferon Regulatory FactorsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Ferritins (Ferritin)IBA 04/2015
1	IronIBA 03/2015
1	GadoliniumIBA 01/2014
1	Myelin-Associated GlycoproteinIBA 09/2012
1	CX3C Chemokine Receptor 1IBA 02/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2011
1	Interleukin-1 (Interleukin 1)IBA 01/2011
1	Atorvastatin (Lipitor)FDA Link 06/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2009
1	CholesterolIBA 03/2008
1	Coenzyme A (CoA)IBA 09/2006
1	Oxidoreductases (Dehydrogenase)IBA 09/2006
1	Peptides (Polypeptides)IBA 12/2005
1	Hemagglutinins (Hemagglutinin)IBA 12/2005
1	Daclizumab (Zenapax)FDA Link 06/2004
1	Androgen Receptors (Androgen Receptor)IBA 04/2003

Therapy/Procedure

11	Therapeutics 01/2021 - 06/2004
2	Immunomodulation 05/2015 - 04/2011
1	Immunotherapy 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2021
1	Secondary Prevention 12/2018
1	Highly Active Antiretroviral Therapy (HAART) 11/2008
1	Organ Transplantation 04/2005
1	Liver Transplantation 04/2005